Cytek Biosciences, Inc.
Cytek Biosciences, Inc. (CTKB) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
ctkb · stock forecast · 5 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 5 Wall Street analysts in the past 3 months
Buy
5 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$5.50
Consensus
$5.13
+27.0% upside
Low
$4.75
Median: $5.125 · Last Close: $4.04
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$5.13
27.0% upside
High Target
$5.5
36.1%
Low Target
$4.75
17.6%
Current Price
$4.04
as of today
Based on analyst price targets, the CTKB stock price prediction for the next 12 months ranges from $4.75 to $5.5. The consensus CTKB price forecast of $5.13 implies 27.0% upside from the current price of $4.04.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $4.18 | ↑ 3.47% |
1-day model range: $4.15–$4.21. Peak: $4.21 (+3.47%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $3 | -31.1% |
| 2028 | $2 | -42.9% |
| 2029 | $2 | -48.2% |
| 2030 | $2 | -50.9% |
| 2031 | — | -52.3% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · CTKB · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-13 | Stephens & Co. | Maintains | Overweight→Overweight |
| 2026-05-12 | Morgan Stanley | Maintains | Equal Weight→Equal Weight |
| 2026-01-08 | TD Cowen | Maintains | Buy→Buy |
| 2025-11-11 | Piper Sandler | Maintains | Overweight→Overweight |
| 2025-05-28 | Morgan Stanley | Maintains | Equal Weight→Equal Weight |
| 2025-05-12 | Goldman Sachs | Maintains | Sell→Sell |
| 2025-03-19 | Stephens & Co. | Maintains | Overweight→Overweight |
| 2025-03-04 | Piper Sandler | Maintains | Overweight→Overweight |
| 2024-11-11 | Piper Sandler | Maintains | Overweight→Overweight |
| 2024-08-13 | Piper Sandler | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on Cytek Biosciences, Inc. (CTKB) stock. Of the recent 30 rating actions, 0 were upgrades and 0 were downgrades. 5 analysts currently cover CTKB.
Analyst Recommendation Trends
CTKB analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$197M
↓ 11.7% YoY
Revenue Next Year
$209M
↑ 6.2% YoY
EPS This Year
$-0.13
EPS Next Year
$-0.35
↑ 173.4% YoY
EPS ForecastReported vs Estimated
Analysts forecast CTKB EPS of $-0.13 for the current fiscal year, based on estimates from 2 analysts. The CTKB revenue forecast is $197M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The CTKB stock forecast is supported by two independent data sources: analyst consensus ratings from 5 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus CTKB price target is $5.13 (+27.0% upside), with an analyst consensus of Buy.
The CTKB short-term stock prediction for tomorrow is $4.18 (+3.47%). The CTKB stock price prediction for 2027 estimates an average of $3. The CTKB stock prediction for 2030 projects a range of $2–$2.
Cytek Biosciences, Inc. trades on NASDAQ under the ticker CTKB. The CTKB stock outlook for 2027 is broadly positive, supported by a Buy consensus among 60% of covering analysts.
Frequently asked questions
CTKB forecast · 8 questionsAccording to 5 Wall Street analysts, the average 12-month CTKB price target is $5.13, with a high forecast of $5.50 and a low of $4.75. The median price target is shown in the chart above when available. This implies +27.0% potential upside from the current price of $4.04.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.